Development and evaluation of a sublingual tablet based on recombinant Bet v 1 in birch pollen-allergic patients.
Nony, E., Bouley, J., Le Mignon, M., Lemoine, P., Jain, K., Horiot, S., Mascarell, L., Pallardy, M., Vincentelli, R., Leone, P., Roussel, A., Batard, T., Abiteboul, K., Robin, B., de Beaumont, O., Arvidsson, M., Rak, S., Moingeon, P.(2015) Allergy 70: 795-804
- PubMed: 25846209 
- DOI: 10.1111/all.12622
- Primary Citation of Related Structures:  
4MNS - PubMed Abstract: 
Sublingual immunotherapy (SLIT) applied to type I respiratory allergies is commonly performed with natural allergen extracts. Herein, we developed a sublingual tablet made of pharmaceutical-grade recombinant Bet v 1.0101 (rBet v 1) and investigated its clinical safety and efficacy in birch pollen (BP)-allergic patients ...